Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy

Despite aggressive treatment, the 5-year event-free survival rate for children with high-risk neuroblastoma is <50%. While most high-risk neuroblastoma patients initially respond to treatment, often with complete clinical remission, many eventually relapse with therapy-resistant tumors. Novel the...

Descripción completa

Detalles Bibliográficos
Autores principales: Valind, Anders, Verhoeven, Bronte Manouk, Enoksson, Jens, Karlsson, Jenny, Christensson, Gustav, Mañas, Adriana, Aaltonen, Kristina, Jansson, Caroline, Bexell, Daniel, Baryawno, Ninib, Gisselsson, David, Hagerling, Catharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980604/
https://www.ncbi.nlm.nih.gov/pubmed/36875552
http://dx.doi.org/10.1080/2162402X.2023.2184130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980604/
https://www.ncbi.nlm.nih.gov/pubmed/36875552
http://dx.doi.org/10.1080/2162402X.2023.2184130

Ejemplares similares